Why Coca-Cola's Q2 2026 beverage volume differs from revenue

Three readings of a beverage quarter

For the three months ended July 3, 2026, Coca-Cola reports worldwide unit-case volume up 5%, concentrate sales volume up 4%, and GAAP net operating revenue up 7%. Those numbers measure related but different events. A drink sold by a bottler, concentrate supplied to a bottler, and revenue recognized by The Coca-Cola Company need not fall in the same reporting period or grow at the same rate.

Whose sale and when?

Reported fact: In the SEC-hosted 10-Q, a unit case represents 192 U.S. fluid ounces of finished beverage, with specified Costa equivalents. Unit-case volume tracks beverages sold directly or indirectly by Coca-Cola and its bottlers to customers or consumers; the filing says the figures rely partly on bottler and distributor estimates. Concentrate sales volume tracks concentrate, syrup, source waters and powders sold or used in finished beverages, expressed in unit-case equivalents.

The ownership of a bottler affects the recognition point. A sale of concentrate to an unconsolidated bottler enters Coca-Cola's concentrate sales when sold to that bottler; its later finished-product sale does not recognize the concentrate again. For consolidated bottlers, the company does not recognize the internal concentrate sale until finished beverages reach a third party. Finished-product operations also generate a different revenue mix from concentrate operations. Inventory timing, supply points, pricing, mix and joint ventures can separate the two volume series.

The specific Q2 gap

Reported fact: Worldwide Q2 unit-case growth of 5% is an average-daily-sales comparison, whereas the 4% concentrate sales growth compares amounts sold during each reporting period. The prior-year quarter ended June 27, 2025. Coca-Cola identifies shipment timing as a contributor to the one-point Q2 difference. The filing's six-month figures are different: 4% unit cases and 6% concentrate sales, with six extra days in Q1 2026 affecting that year-to-date comparison. The six-month reporting-day effect must not be claimed as the explanation for the Q2 one-point gap.

Calculation: The Q2 rates differ by one percentage point; reported revenue increased $845 million, from $12,535 million to $13,380 million, or 6.7% before rounding to the issuer's 7%. The one-point volume difference is not a one-point GAAP revenue adjustment.

Revenue also reflects value and translation

Reported fact: Coca-Cola's own estimated consolidated revenue-change table attributes rounded impacts of 4% to volume, 2% to price/mix, 2% to currency and −1% to acquisitions/divestitures, totaling 7%, with rounding caveats. Its geographic segment volume component generally follows concentrate sales; Bottling Investments uses finished-product unit cases after structural changes. The table is an issuer analysis of revenue change, not a formula made by adding worldwide unit-case growth to unrelated percentages.

Interpretation: Consumer-level beverage activity and the company's reported dollars can both rise without matching. The Q2 revenue growth incorporates which entity sold a product, shipment timing, pricing and product/geographic mix, foreign-currency translation and structural changes. The 5% unit-case number alone is not revenue growth.

Limits and source

Limitation: The filing does not give a transaction-level reconciliation from estimated global consumer unit cases to GAAP dollars. Segment percentages are rounded; joint ventures and bottler ownership complicate comparisons. Neither a volume rate nor a price/mix rate is a forecast of earnings.

Primary source: The Coca-Cola Company, Q2 2026 Form 10-Q, MD&A “Beverage Volume” and “Net Operating Revenues,” quarter ended July 3, 2026; filed July 29, 2026, accession 0001628280-26-050503. the SEC-hosted 10-Q.

Continue with the underlying research

This question-focused analysis complements the broader permanent KO company research. Arqaris methodology explains how to read reported facts, calculations and limitations. This is historical filing analysis, not an investment recommendation, price target or stock forecast.